Preparation method of triple egg yolk antibody for resisting vibrio harveyi, vibrio alginolyticus and vibrio parahaemolyticus
By preparing triple yolk antibodies against Vibrio harveri, Vibrio algaelibri and Vibrio parahaemolytica, the drug resistance and pollution problems brought by antibiotics and chemical drugs are solved, and effective inhibition, safety and low levels of Vibrio are achieved. Cost of disease prevention and treatment.
Patent Information
- Application Number
- CN202411038551.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, antibiotics and chemical drugs are dependent on disease prevention and treatment caused by Vibrio Harvestris, Vibrio algae and Vibrio parahaemolyticus, resulting in increased drug resistance, water pollution and food safety risks, and a safe and effective alternative method.
The preparation method of triple yolk antibodies against Vibrio harveri, Vibrio algae and Vibrio parahaemolytica is prepared. After Vibrio is inoculated and inactivated, antibodies are extracted using immune eggs to prepare triple yolk with strong specificity and high purity. Antibodies, used for disease prevention and treatment.
It has achieved effective inhibition of Vibrio Harvested, Vibrio algae and Vibrio parahaemolyticus, which is low-cost, safe and non-toxic, easy to industrially produce, suitable for large-scale applications, and does not cause environmental pollution.
Smart Images

Figure CN119019550A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to biotechnology and application fields, and more specifically, to a method for preparing a triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus. Background Art
[0002] Vibrio harveyi, Vibrio alginolyticus and Vibrio parahemolyticus are common Gram-negative halophilic bacteria in marine environments, belonging to the order Vibrionales, family Vibrionaceae, and genus Vibrio. Vibrio harveyi can infect a variety of marine vertebrates and invertebrates, and is the main pathogen in shrimp farming. In addition to causing disease and mass death in shrimp, Vibrio harveyi can also cause infection in fish such as sea bass, sunfish, and grouper. Vibrio alginolyticus is a conditional pathogen that causes infection in aquatic organisms such as fish, shrimp, shellfish, and crabs. When the water temperature is 25℃ to 35℃, it is most likely to cause a large-scale epidemic of Vibrio alginolyticus. Because it is highly pathogenic, aquatic animals will develop symptoms quickly and have a high mortality rate after infection. Vibrio alginolyticus infection of grouper will cause symptoms such as surface ulceration, bleeding in the gills and fins. Vibrio parahaemolyticus has a wide range of hosts and can cause disease in dozens of marine fish species, including flounder, turbot, grouper, etc. The main epidemic period of Vibrio parahaemolyticus disease is in summer and autumn every year, among which the infection rate of marine fish and shrimp is relatively high, usually about 50% of the total number, and the infection rate reaches the highest in summer, accounting for about 90% of the total amount of marine fish and shrimp. At present, Vibrio parahaemolyticus has become one of the reasons that endanger the quality of seafood and hinder the economic growth of aquaculture, especially for large-scale marine fish, and the mortality rate of infected fish can reach more than 30%.
[0003] At present, the main means of prevention and treatment of diseases caused by Vibrio harveyi, Vibrio alginolyticus, and Vibrio parahaemolyticus are as follows: antibiotics and chemical drugs, Chinese herbal medicines, inactivated vaccines, and antibodies. Among them, antibiotics and chemical drugs are widely used. However, with the long-term abuse of antibiotics and chemical drugs, many disadvantages have been brought: ① Pathogens develop drug resistance, resulting in a significant reduction in the effectiveness of antibiotics, or even ineffectiveness; ② Cause serious water pollution and cause imbalance of the microecology of the water environment; ③ Antibiotic residues appear in animals, affecting the food quality and safety of aquatic products and indirectly endangering human health. Therefore, there is an urgent need for a new technology and new product that can effectively control diseases of aquatic animals without causing toxic side effects, so as to partially or completely replace existing antibiotics or chemical drugs and achieve healthy breeding, which has become a hot spot and difficulty in current research.
[0004] Egg yolk immunoglobulin (IgY) has become an effective alternative to antibiotics and chemical drugs due to its strong specificity, high efficiency, no toxic side effects and no pollution to the environment. Egg yolk antibodies have the characteristics of low cost, high efficiency, convenient production, high yield and simple preparation. They have been widely concerned as an effective method for disease prevention and control. Compared with traditional antibiotics and chemical drugs, the application of egg yolk antibodies has the following advantages: ① Strong specificity: Unlike broad-spectrum antibiotics, egg yolk antibodies only target corresponding pathogens and will not affect other bacteria. ② Easy to obtain: Egg yolk antibodies can be obtained from eggs of immunized laying hens, without slaughtering a large number of animals, and the antibodies produced are high in titer and strong in stability. ③ There is a certain phylogenetic distance between poultry and mammals, and a small amount of antigen can induce an effective immune response. ④ No residue: Since egg yolk antibodies are dry immunoglobulins, they will be digested and absorbed by the body as nutrients after they take effect. ⑤ Short R&D cycle, low cost, long-term storage, easy transportation and application. Yolk antibodies are widely used in the prevention and treatment of animal diseases and disease diagnosis. The U.S. Food and Drug Administration (FDA) has listed yolk antibodies as "Generally Recognized As Safe (GRAS)". Specific yolk antibodies can protect, prevent and treat diseases in aquatic animals through feeding, injection and immersion. They can also be used in immunological testing, aquatic product preservation and disease diagnosis.
[0005] Therefore, the present invention proposes a triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus and a preparation method thereof to solve the above technical problems. Summary of the invention
[0006] In order to overcome the above-mentioned defects existing in the prior art, the present invention provides a method for preparing a triple egg yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus. The triple egg yolk antibody prepared by the present invention has strong specificity and high purity, and has a strong inhibitory effect on Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus. At the same time, the antibody preparation cost is low, convenient and simple, and is suitable for large-scale production.
[0007] The above technical objectives of the present invention are achieved through the following technical solutions: A method for preparing triple yolk antibodies against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, comprising the following steps:
[0008] S1. Prepare and inactivate antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, wherein the preparation method of antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus is as follows:
[0009] (1) Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were inoculated into 2216E and LB liquid culture media, respectively. Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were cultured in a constant temperature shaker at 30° C. and 37° C. overnight, and the cells were collected by centrifugation. The cells were washed with PBS buffer for 3 times to obtain a bacterial suspension.
[0010] (2) Add 4% paraformaldehyde fixative to a final concentration of 0.4% and inactivate at room temperature for 24 h;
[0011] (3) Wash the cells with PBS buffer for 4 times, mix the centrifuged cell pellet with PBS buffer, mix Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus in a ratio of 1:1, adjust the bacterial suspension concentration to 3×108 CFU / mL, and obtain inactivated Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus antigens, and store in a 4°C refrigerator for later use;
[0012] S2. Immunize healthy laying hens with antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus. Perform one basic immunization and three booster immunizations on the immunized laying hens. Collect the immunized eggs every Sunday after the first immunization and store them in a refrigerator at 4°C for future use.
[0013] S3, separating and purifying the yolk of the immune chicken eggs to obtain triple yolk antibodies against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, the specific steps are as follows:
[0014] (1) Wipe the eggshell of the immunized egg with alcohol, separate the yolk with a yolk separator, then add pre-cooled sterile distilled water 7 times the volume of the yolk to the yolk, adjust the pH concentration to 5.0 with 0.1 M HCl, mix well and let stand at 4°C overnight;
[0015] (2) centrifuging at 4°C and 12,000 g for 25 min, filtering the supernatant with 0.45 μm and 0.2 μm microporous membranes in turn to obtain the water-soluble component of the egg yolk antibody;
[0016] (3) Add ammonium sulfate to the water-soluble component of the egg yolk antibody to a saturation of 55%, stir well and incubate at 4°C overnight, centrifuge at 4°C, 12,000 g for 20 min, dilute the precipitate with PBS buffer to the original volume, add ammonium sulfate to a saturation of 33%, stir well and incubate at 4°C for 2 h, centrifuge at 4°C, 12,000 g for 20 min, resuspend the precipitate with PBS buffer, and obtain triple egg yolk antibodies to Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus.
[0017] Furthermore, in step S1, formaldehyde is used for inactivation, and the specific method is: add paraformaldehyde fixative to the bacterial liquid of Vibrio harveyi, Vibrio alginolyticus, and Vibrio parahaemolyticus respectively to make the final concentration of 0.4%, stand at room temperature for 24 hours, centrifuge to remove formaldehyde, wash the bacteria with PBS buffer and adjust the concentration.
[0018] Furthermore, in step S2, the basic immunization is to add an equal amount of Freund's complete adjuvant to the antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus mixed in a 1:1 ratio, and inject the immunization after sufficient emulsification; the booster immunization is to add an equal amount of Freund's incomplete adjuvant to the antigens of the three Vibrio mixed in an equal ratio, and inject the immunization after sufficient emulsification.
[0019] The invention discloses a method for preparing a triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus and an application of the prepared triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus in immunological detection.
[0020] In summary, the present invention has the following beneficial effects:
[0021] (1) The triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus of the present invention is obtained by immunizing healthy egg-laying hens with antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, and has the advantages of good specificity, high purity and high titer. The prepared triple yolk antibody has a strong inhibitory effect on Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, and can be used for the prevention and treatment of diseases caused by Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, as well as immunological detection.
[0022] (2) The triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus described in the present invention uses eggs laid by healthy hens as carriers, which is simple to prepare, safe and non-toxic, low in cost, high in yield, and easy to industrialize. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 This is a titer diagram of the triple yolk antibody in Example 2 of the present invention (A: Vibrio harveyi, B: Vibrio alginolyticus, C: Vibrio parahaemolyticus);
[0024] Figure 2 This is the reduced SDS-PAGE gel electrophoresis diagram of the triple yolk antibody in Example 3 of the present invention (M: Protein Maker; 1: WSF; 2: first salting out; 3: second salting out);
[0025] Figure 3 This is a Western Blot image of the triple yolk antibody in Example 4 of the present invention (A: Vibrio harveyi; B: Vibrio alginolyticus; C: Vibrio parahaemolyticus);
[0026] Figure 4It is a scanning electron micrograph of the triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus in Example 5 of the present invention (A: Vibrio harveyi; B: Vibrio alginolyticus; C: Vibrio parahaemolyticus; (a): triple yolk antibody; (b): non-specific yolk antibody);
[0027] Figure 5 These are confocal laser scanning microscopy images of the triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus in Example 6 of the present invention (A: Vibrio harveyi; B: Vibrio alginolyticus; C: Vibrio parahaemolyticus; (a): triple yolk antibody; (b): non-specific yolk antibody; (c): blank group);
[0028] Figure 6 This is a diagram showing the in vitro antibacterial effect of the triple egg yolk antibody in Example 7 of the present invention on Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus (A: Vibrio harveyi; B: Vibrio alginolyticus; C: Vibrio parahaemolyticus). DETAILED DESCRIPTION
[0029] The following is combined with Figure 1-6 The present invention is described in further detail.
[0030] Example 1: A method for preparing a triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, comprising the following steps:
[0031] Preparation of Vibrio antigens:
[0032] Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were inoculated into 2216E and LB liquid culture media, respectively. Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were cultured in a constant temperature shaker at 30°C and 37°C, respectively, overnight. The cells were collected by centrifugation and washed three times with PBS buffer to obtain a Vibrio suspension.
[0033] Inactivation of Vibrio antigens:
[0034] 4% paraformaldehyde fixative was added to the bacterial suspension to a final concentration of 0.4%, and inactivated at room temperature for 24 hours. The bacteria were washed 4 times with PBS buffer, and the bacterial sediment after centrifugation was mixed with PBS buffer. Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were mixed in a 1:1 ratio, and the concentration of the bacterial solution was adjusted to 3x108CFU / mL, and inactivated Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus antigens were obtained, and placed in a 4°C refrigerator for use.
[0035] Immunize laying hens and collect eggs:
[0036] The laying hens were given one basic immunization and three booster immunizations. An equal amount of Freund's complete adjuvant was added to the inactivated Vibrio antigen. After full emulsification, the laying hens were injected into the breast muscle for immunization. The immunization dose was 1 mL / hen. For booster immunization, an equal amount of Freund's incomplete adjuvant was added to the inactivated Vibrio antigen. After full emulsification, the laying hens were injected into the breast muscle for immunization. The immunization dose was 1.5 mL / hen. Each immunization was separated by 10 days. Eggs were collected every Sunday after the first immunization and stored in a refrigerator at 4°C for future use.
[0037] Isolation of yolk antibodies from egg yolk:
[0038] The eggshell of the immune egg was wiped with alcohol, and the yolk was separated by a yolk separator. Then, pre-cooled sterile distilled water 7 times the volume of the yolk was added to the yolk, and the pH concentration was adjusted to 5.0 with 0.1M HCl. After mixing, it was placed in a refrigerator at 4°C overnight. Then, it was centrifuged at 4°C and 12000g for 25 minutes, and the supernatant was filtered with 0.45μm and 0.2μm microporous membranes in turn, which was the water-soluble component (WSF) of the yolk antibody.
[0039] Purification of yolk antibodies:
[0040] Add ammonium sulfate to the water-soluble component of the yolk antibody to a saturation of 55%, stir well and incubate at 4°C overnight, centrifuge at 4°C, 12000g for 20 min, dilute the precipitate with PBS buffer to the original volume, add ammonium sulfate to a saturation of 33%, stir well and incubate at 4°C for 2 h, centrifuge at 4°C, 12000g for 20 min, resuspend the precipitate with PBS buffer to obtain the triple yolk antibody.
[0041] Example 2: Determination of the titer of triple yolk antibodies against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus
[0042] The concentration of formaldehyde-inactivated Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus was adjusted to 10 8CFU / mL, used for coating of 96-well plates, 100 μL per well, and stand overnight in a 4°C refrigerator. The next day, pour out the liquid in the wells, wash 3 times with PBST, add blocking solution, 200 μL per well, and block at 37°C for 2h. After washing 3 times with PBST, dilute the WSF antibody diluent prepared in Example 4 at a gradient of 1:100, 1:200, 1:400, 1:800, 1:1600, 1:3200, 1:6400, 1:12800, 1:25600, 1:51200, etc., add 100 μL to each well, incubate at 37°C for 2h, and use non-specific WSF of the corresponding dilution multiple as a negative control, with 3 replicates for each gradient. Wash 3 times with PBST, add 100 μL of 1:100000 diluted horseradish peroxidase-labeled rabbit anti-chicken IgY as secondary antibody to each well, incubate at 37°C for 1 hour, wash 5 times, add TMB substrate colorimetric solution, incubate at room temperature in the dark for 20 minutes, then add 2 mol / L H2SO4 to terminate the reaction, read the absorbance value at a wavelength of 450 nm with an enzyme reader, the ratio of the OD value of the sample to be tested to the negative control is ≥2.1, which is the titer value, and the maximum dilution multiple of the corresponding sample is the titer of the anti-river Vibrio yolk antibody. The results are shown in the attached Figure 1 , the four red arrows indicate the time of the first immunization, the second immunization, the third immunization, and the fourth immunization, each with an interval of 10 days; Figure 1 It can be seen that the titer increased slowly after the first immunization and increased significantly after 4 weeks. Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus reached their peak values (1:51200) in the 6th and 7th weeks, respectively, lasted for about 5 weeks, and then gradually decreased.
[0043] Example 3: Purity determination of triple yolk antibodies against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus:
[0044] The triple yolk protein prepared by the method proposed in the present invention was used for IgY purity identification and detected by 12% reduced SDS-PAGE. The results are shown in the attached Figure 2 , where lane marker: protein marker; lane 1: water-soluble fraction (WSF) of egg yolk antibody; lane 2: solution obtained after the first salting out of ammonium sulfate; lane 3: solution obtained after the second salting out of ammonium sulfate. The results showed that egg yolk antibody is composed of two heavy chains and two light chains, with the heavy chain and light chain being about 68kDa and 25kDa respectively, which is consistent with literature reports.
[0045] Example 4: Western blot specificity detection of triple yolk antibodies against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus:
[0046] Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were incubated with triple yolk antibody and non-specific yolk antibody at room temperature for 2 hours, boiled and centrifuged, and subjected to 10% reduced SDS-PAGE electrophoresis. The proteins on the gel were transferred to a nitrocellulose membrane using a semi-dry method and blocked with a blocking solution (TBST solution containing 5% skim milk powder) at room temperature for 2 hours. Washed 5 times, and then incubated with 1:5000 diluted horseradish peroxidase-labeled rabbit anti-chicken IgY at room temperature for 1 hour. After washing 5 times, ECL chemiluminescent ultrasensitive colorimetric reagent was used for color development in the dark. The results are shown in the attached Figure 3 , indicating that the secondary antibody can specifically bind to the triple yolk antibody and can be recognized and displayed as the corresponding protein bands.
[0047] Example 5: Scanning electron microscopy observation of the effect of triple yolk antibody on the surface structure of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus:
[0048] WSF with triple yolk antibody and WSF with nonspecific yolk antibody were ultrafiltered to a final concentration of 16 mg / mL, mixed with 2216E and LB liquid culture medium in equal proportions, and sterilized by filtration with a 0.2 μm microporous filter membrane. The concentrations of Vibrio harveyi, Vibrio alginolyticus, and Vibrio parahaemolyticus were adjusted to 10 6 CFU / mL, incubated at 37℃ for 2h. Centrifuged at 4000g for 10min, washed 3 times with PBS, added 2mL of 2.5% glutaraldehyde fixative at room temperature for 2h, temporarily stored in a 4℃ refrigerator, and sent to Wuhan Saiweier Biotechnology Co., Ltd. for testing. The results are attached. Figure 4 Compared with nonspecific egg yolk antibodies, the bacterial surfaces of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus under the action of triple egg yolk antibodies were rough, with irregular edges, and the bacteria agglutinated and adhered to each other.
[0049] Example 6: Confocal laser scanning microscopy observation of the affinity of triple yolk antibody to Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus:
[0050] The concentration of inactivated Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus was adjusted to 10 6 CFU / mL, take 750μL bacterial solution, add equal volumes of triple yolk antibody, nonspecific yolk antibody (16mg / mL) and PBS solution, and incubate at 37℃ for 2h. Wash 3 times with PBS, add 400μL FiTC-labeled rabbit anti-chicken IgG (1:200 dilution), and incubate at 37℃ in the dark for 2h. After washing 4 times with PBS and resuspending, draw 10μL bacterial solution and drop it on the slide, and fix it with a coverslip. Use confocal laser scanning microscopy to detect bacterial activity. The results are attached. Figure 5 , compared with the non-specific yolk antibody group ( Figure 5 b) and blank group ( Figure 5 c), prepared triple yolk antibody group ( Figure 5 In a), more fluorescent labels can be observed, indicating that the prepared triple yolk antibody has a strong specific binding ability with Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, and the affinity of FITC-labeled IgG and IgY is good.
[0051] Example 7: In vitro antibacterial test:
[0052] WSF with triple yolk antibody and non-specific yolk antibody were ultrafiltered and concentrated by ultrafiltration concentrators, and the antibody concentrations were adjusted by ultramicrospectrophotometer to 2 mg / mL, 4 mg / mL, 8 mg / mL, and 16 mg / mL, respectively. 2216E and LB liquid culture medium without yolk antibody were used as blank controls. All solutions were sterilized by filtration through a 0.2 μm microporous filter membrane. Vibrio harveyi, Vibrio alginolyticus, and Vibrio parahaemolyticus in the logarithmic growth phase were taken and resuspended in PBS to a concentration of 10 5 CFU / mL, take 3mL of bacterial solution and mix it with different concentrations of triple yolk antibody, non-specific yolk antibody and PBS solution in a ratio of 1:1. Place the mixture in a 30℃ constant temperature oscillator (160rpm) for shaking culture, and take 150μL every 2h to measure OD620 nm Absorbance. See attached for the results. Figure 6 , indicating that the prepared triple yolk antibody has a significant inhibitory effect on Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, and is dose-dependent.
[0053] This specific embodiment is merely an explanation of the present invention and is not a limitation of the present invention. After reading this specification, those skilled in the art may make non-creative modifications to the present embodiment as needed. However, as long as they are within the scope of the claims of the present invention, they are protected by the patent law.
Claims
1. A method for preparing a triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, characterized in that: The following steps are involved: S1. Prepare and inactivate antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, wherein the preparation method of antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus is as follows: (1) Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were inoculated into 2216E and LB liquid culture media, respectively. Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus were cultured in a constant temperature shaker at 30° C. and 37° C. overnight, and the cells were collected by centrifugation. The cells were washed with PBS buffer for 3 times to obtain a bacterial suspension. (2) Add 4% paraformaldehyde fixative to a final concentration of 0.4% and inactivate at room temperature for 24 h; (3) Wash the cells with PBS buffer for 4 times, mix the centrifuged cell pellet with PBS buffer, mix Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus in a ratio of 1:1, adjust the bacterial suspension concentration to 3×108 CFU / mL, and obtain inactivated Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus antigens, and store in a 4°C refrigerator for later use; S2. Immunize healthy laying hens with antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus. Perform one basic immunization and three booster immunizations on the immunized laying hens. Collect the immunized eggs every Sunday after the first immunization and store them in a refrigerator at 4°C for future use. S3, separating and purifying the yolk of the immune chicken eggs to obtain triple yolk antibodies against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus, the specific steps are as follows: (1) Wipe the eggshell of the immunized egg with alcohol, separate the yolk with a yolk separator, then add pre-cooled sterile distilled water 7 times the volume of the yolk to the yolk, adjust the pH concentration to 5.0 with 0.1 M HCl, mix well and let stand at 4°C overnight; (2) centrifuging at 4°C and 12,000 g for 25 min, filtering the supernatant with 0.45 μm and 0.2 μm microporous membranes in turn to obtain the water-soluble component of the egg yolk antibody; (3) Add ammonium sulfate to the water-soluble component of the egg yolk antibody to a saturation of 55%, stir well and incubate at 4°C overnight, centrifuge at 4°C, 12,000 g for 20 min, dilute the precipitate with PBS buffer to the original volume, add ammonium sulfate to a saturation of 33%, stir well and incubate at 4°C for 2 h, centrifuge at 4°C, 12,000 g for 20 min, resuspend the precipitate with PBS buffer, and obtain triple egg yolk antibodies to Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus.
2. The method for preparing the triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus according to claim 1, characterized in that: In step S1, formaldehyde is used for inactivation. The specific method is as follows: paraformaldehyde fixative is added to the bacterial suspensions of Vibrio harveyi, Vibrio alginolyticus, and Vibrio parahaemolyticus respectively to a final concentration of 0.4%. After standing at room temperature for 24 hours, the formaldehyde is removed by centrifugation, and the bacteria are washed with PBS buffer and the concentration is adjusted.
3. The method for preparing the triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus according to claim 1, characterized in that: In step S2, the basic immunization is to add an equal amount of Freund's complete adjuvant to the antigens of Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus mixed in a ratio of 1:1, and inject the immunization after sufficient emulsification; the booster immunization is to add an equal amount of Freund's incomplete adjuvant to the antigens of the three Vibrio mixed in an equal ratio, and inject the immunization after sufficient emulsification.
4. Use of the triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus prepared by the method for preparing the triple yolk antibody against Vibrio harveyi, Vibrio alginolyticus and Vibrio parahaemolyticus according to claim 1 in immunological detection.
